NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / World News / Moderna's COVID-19 vaccine goes into final human trial stage
    Next Article
    Moderna's COVID-19 vaccine goes into final human trial stage

    Moderna's COVID-19 vaccine goes into final human trial stage

    By Shubham Sharma
    Jul 27, 2020
    09:12 pm

    What's the story

    In a major development, the COVID-19 vaccine developed by biotech giant Moderna Therapeutics has gone into the third and final stage of clinical human trials.

    The late-stage study, first one to have started by the United States, is the last step before the vaccine candidate is lined up for regulatory review and emergency-use approvals.

    Here are the details of the trial.

    Trial

    Vaccine being tested on 30,000 participants

    As part of the Phase-3 trial, Moderna is administering its experimental shot, dubbed mRNA-1273, on as many as 30,000 volunteers - people who are healthy and have not been infected by the novel coronavirus disease.

    The trial is set across 89 US sites, including the Washington DC and some worst-hit regions like Texas, California, Florida, Georgia, Arizona, and North and South Carolina.

    Details

    What will happen in the trial?

    The study, as explained by Moderna, is a randomized, observer-blind, placebo-controlled trial to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19 for up to 2 years.

    Under this, a select group of participants will get two 100 microgram shots of the vaccine in a gap of 28 days, while the others, a control group, will get a placebo for comparison.

    Monitoring

    Participants will be monitored in the months to come

    Once the participants are injected, they will be allowed to go about their daily routines and monitored/tested to see how effectively and safely the shot works on them.

    The main goal of the study is to see if the vaccine could prevent COVID-19 symptoms after two doses, while the secondary objectives include whether it could prevent severe COVID-19 case or death caused by it.

    Results

    So far, the results have been promising

    The Moderna vaccine, developed jointly by Moderna and US NIAID, has seen some delays to go into the final trials, but the results from early-stage tests have shown promise.

    In the Phase-1, the shot was tested on 45 healthy volunteers and was able to generate an immune response against the virus in all the cases, without any major side effects.

    Quote

    Here is what NIAID's Director says on the Phase-3 trial

    "Results from early-stage clinical testing indicate the investigational mRNA-1273 vaccine is safe and immunogenic," said Dr. Anthony Fauci, NIAID's Director. "This scientifically rigorous, randomized, placebo-controlled trial is designed to determine if the vaccine can prevent COVID-19 and for how long such protection may last."

    Availability

    Possible availability in early 2021

    If all goes according to the plan and the vaccine achieves the primary and secondary objectives, the data generated from the late-stage trial will be submitted to the Food and Drug Administration (FDA) for review.

    After that, the authority should issue emergency use authorization for the vaccine, possibly making it available for public use by early 2021.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    United States of America
    NIAID
    COVID-19
    Moderna Therapeutics

    Latest

    You can now order limited-edition, chef-curated dishes on Swiggy Swiggy
    Why Cognizant employees have to work from home in Bengaluru Cognizant
    This is why Mars's sky turned green this week Mars
    EU wants to restrict social media for children under 16 Europe

    United States of America

    Aprilia RSV4, Tuono RR Misano edition launched in the US Aprilia
    Harvard, MIT sue Trump administration over international student visa rules Donald Trump
    Now, Walmart is bringing an Amazon Prime-like membership service Walmart
    This 'air filter' can kill novel coronavirus: Here's how University of Houston

    NIAID

    41 dead in Ebola's latest outbreak in DR Congo World Health Organization
    New COVID-19 drug has 'clear cut' positive effect: Dr. Fauci United States of America
    US expert offers an optimistic timeline for coronavirus vaccine Vaccine

    COVID-19

    CBSE Class-12 results: This Lucknow girl has scored perfect 100% Lucknow
    Russell Westbrook tests positive for coronavirus ahead of NBA season NBA
    EPL clubs open to July 27-October 5 summer transfer window Football
    Bihar: 75 BJP leaders, HQ staff test positive for COVID-19 Bihar

    Moderna Therapeutics

    US begins human trials of coronavirus vaccine: Details here United States of America
    COVID-19 vaccine not guaranteed, says leading world health expert World Health Organization
    Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial Oxford University
    Moderna's COVID-19 vaccine shows 'positive' results in human trials United States of America
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025